Article

Mmvtelegraph.com on 2022-11-02 09:58

Eli Lilly CEO on slicing tips, potential weight problems drug, Alzheimer’s trial

Eli Lilly (LLY) CEO David Ricks expressed optimism on the drugmaker's innovation pipeline on Tuesday, a stance we share despite Club Holding's cluttered

Related news

MWeight problems and Alzheimer’s medicine pack one-two punch to carry Eli Lilly mvtelegraph.com
Utah , Provo , Lower Austria , Japan , Denmark
MEli Lilly weight reduction drug tirzepatide knowledge launched mvtelegraph.com
Utah , Provo
IEli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’invezz.com
Wall Street , China , North America
FEli Lilly raises Alzheimer’s drug hopes ft.com
Washington
FAstraZeneca and Eli Lilly scrap Alzheimer’s trial ft.com
Weight loss, diabetes drugs propel Eli Lilly to better-than-expected forecast for 2024 Seattle Times
Japan
DEli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlook dcourier.com
Europe , Wall Street
MJim Cramer’s Investing Membership Assembly Tuesday: CPI Information, Eli Lilly mvtelegraph.com
Lower Austria , Wall Street , China
Eli Lilly applies for FDA approval on Alzheimer’s drug nwaonline.com
Rochester , San Francisco , New York , Amsterdam , Indianapolis
Eli Lilly says experimental drug slows Alzheimer’s worsening Hartford Courant
Indianapolis
Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial success Financial Times
Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials wsj.com
Eli Lilly: Experimental Alzheimer’s drug shows some benefit reviewtimes.com
Amsterdam , Mayo Clinic
FEli Lilly chief seeks to recover from Alzheimer’s drug flop ft.com
South East Asia , China
Dementia: Eli Lilly drug shown to slow Alzheimer’s progression Financial Times